Abbott India up after Q4 profit rise, top pharma index gainer
** Shares of Abbott India ABOT.NS up 3.5%, after a 4.8%
climb earlier in the session
** Drugmaker reported 24% rise in profit while rev rose 7%
** Brokerage CLSA sees sustained growth for the Digene
antacid maker, retains "outperform" rating and 27,780 rupees PT
** ABOT top pct gainer in Nifty Pharma index .NIPHARM ,
which is up 1.3%
** Trading vols 2.4x 30-day avg
** YTD stock had risen ~16%
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Abbott India
See all newsJP Morgan downgrades Abbott India to 'neutral' citing growth headwinds
Brief: Abbott India Partners With Novo Nordisk India To Launch Extensior
Brief: Abbott India Dec-Quarter Profit 3.76 Billion Rupees
Brief: Abbott India Receives Tax Penalty Of 24 Million Rupees
Brief: Central Government Approves Kartik Rajendran As MD of Abbott India